Related Experiment Videos
Glutamine transport and human hepatocellular transformation
1Massachusetts General Hospital Division of Surgical Oncology and Harvard Medical School, Boston 02114-2696, USA.
JPEN. Journal of Parenteral and Enteral Nutrition
|September 14, 1999
Summary
Hepatoma cells exhibit altered glutamine transport, potentially explaining low plasma glutamine in liver cancer (HCC). Targeting glutamine transporters like System ASC may offer a therapeutic strategy for HCC.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- The liver regulates glucose and nitrogen metabolism, with glutamine acting as a key gluconeogenic substrate and ammonia shuttle.
- Hepatic metabolic zonation, particularly glutamine metabolism, is crucial for maintaining whole-body homeostasis.
- System N transporters regulate glutamine uptake in normal hepatocytes, influencing ammonia and glucose balance.
Purpose of the Study:
- To investigate the role of glutamine transport in hepatocellular carcinoma (HCC).
- To understand the differences in glutamine uptake between normal hepatocytes and hepatoma cells.
- To explore potential therapeutic targets for HCC based on glutamine transporter activity.
Main Methods:
- Comparative analysis of glutamine transporter expression and activity in normal hepatocytes versus hepatoma cells.
- Investigation of glutamine transport kinetics using System N and System ASC/B0 characteristics.
- Assessment of glutamine transport's impact on hepatoma cell growth.
Main Results:
- Hepatoma cells display significantly higher glutamine uptake rates compared to normal hepatocytes.
- This enhanced uptake is mediated by high-affinity transporters, likely System ASC or B0, rather than System N.
- Glutamine transport via System ASC influences growth in some human hepatoma cells.
Conclusions:
- Altered glutamine transporter expression in hepatoma cells leads to net glutamine consumption.
- This consumption may contribute to the hypoglutaminemia observed in HCC patients.
- System ASC transporter represents a potential therapeutic target for HCC.